Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor site/build update.
    Difference
    0.1%
    Check dated 2026-09-01T19:12:30.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the prior Revision: v3.6.4, indicating a small software update rather than any changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T06:19:16.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The site footer now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates a platform update with no changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-28T02:56:42.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a maintenance update to the page. There are no visible content or functionality changes indicated by the provided data.
    Difference
    0.0%
    Check dated 2026-07-06T16:11:31.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.0 to v3.6.2, signaling a recent update to the study details page.
    Difference
    0.0%
    Check dated 2026-06-29T08:43:28.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    New guidance sections were added to help users read the study record, answer common questions, and learn how to join, and the Intervention/Treatment label was updated. The recruitment status now shows 'No longer looking for participants', indicating enrollment has ended.
    Difference
    0.4%
    Check dated 2026-06-15T05:33:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.